Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX) approved a 1-for-8 reverse stock split of its common stock and a decrease in the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE